blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2089360

EP2089360 - SPIROINDOLINONE DERIVATIVES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.04.2012
Database last updated on 30.09.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU
published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[N/P]
Former [2009/34]For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / LIU, Jin-Jun
50 Highmount Avenue
Warren, New Jersey 07059 / US
02 / ZHANG, Zhuming
59 Wesley Road
Hillsborough, New Jersey 08844 / US
 [2009/34]
Representative(s)Beyermann, Jochen Carl
F. Hoffmann-La Roche AG CLP - Patent Department Grenzacherstrasse 124
4070 Basel / CH
[2011/19]
Former [2009/34]Bastian, Werner Maria, et al
Vossius & Partner Siebertstrasse 4
81675 München / DE
Application number, filing date07822025.830.10.2007
[2009/34]
WO2007EP61671
Priority number, dateUS20060858039P09.11.2006         Original published format: US 858039 P
[2009/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008055812
Date:15.05.2008
Language:EN
[2008/20]
Type: A1 Application with search report 
No.:EP2089360
Date:19.08.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 15.05.2008 takes the place of the publication of the European patent application.
[2009/34]
Type: B1 Patent specification 
No.:EP2089360
Date:08.06.2011
Language:EN
[2011/23]
Search report(s)International search report - published on:EP15.05.2008
ClassificationIPC:C07D209/54
[2009/34]
CPC:
C07D209/54 (EP,KR,US); A61K31/404 (KR); A61P35/00 (EP);
C07D401/04 (EP,KR,US); C07D409/04 (EP,KR,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/34]
TitleGerman:SPIROINDOLINONDERIVATE[2009/34]
English:SPIROINDOLINONE DERIVATIVES[2009/34]
French:DERIVES DE SPIROINDOLIDONE[2009/34]
Entry into regional phase09.06.2009National basic fee paid 
09.06.2009Designation fee(s) paid 
09.06.2009Examination fee paid 
Examination procedure20.05.2008Request for preliminary examination filed
International Preliminary Examining Authority: EP
09.06.2009Examination requested  [2009/34]
08.09.2009Despatch of a communication from the examining division (Time limit: M04)
05.01.2010Reply to a communication from the examining division
29.01.2010Despatch of a communication from the examining division (Time limit: M04)
08.06.2010Reply to a communication from the examining division
22.02.2011Communication of intention to grant the patent
21.04.2011Fee for grant paid
21.04.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.09.2009
Opposition(s)09.03.2012No opposition filed within time limit [2012/20]
Fees paidRenewal fee
07.10.2009Renewal fee patent year 03
23.09.2010Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT08.06.2011
BE08.06.2011
CY08.06.2011
CZ08.06.2011
DK08.06.2011
EE08.06.2011
FI08.06.2011
HU08.06.2011
LT08.06.2011
LV08.06.2011
MT08.06.2011
NL08.06.2011
PL08.06.2011
RO08.06.2011
SE08.06.2011
SI08.06.2011
SK08.06.2011
TR08.06.2011
BG08.09.2011
GR09.09.2011
IS08.10.2011
PT10.10.2011
IE30.10.2011
LU30.10.2011
MC31.10.2011
[2013/45]
Former [2013/44]AT08.06.2011
BE08.06.2011
CY08.06.2011
CZ08.06.2011
DK08.06.2011
EE08.06.2011
FI08.06.2011
LT08.06.2011
LV08.06.2011
MT08.06.2011
NL08.06.2011
PL08.06.2011
RO08.06.2011
SE08.06.2011
SI08.06.2011
SK08.06.2011
TR08.06.2011
BG08.09.2011
GR09.09.2011
IS08.10.2011
PT10.10.2011
IE30.10.2011
LU30.10.2011
MC31.10.2011
Former [2013/29]AT08.06.2011
BE08.06.2011
CY08.06.2011
CZ08.06.2011
DK08.06.2011
EE08.06.2011
FI08.06.2011
LT08.06.2011
LV08.06.2011
MT08.06.2011
NL08.06.2011
PL08.06.2011
RO08.06.2011
SE08.06.2011
SI08.06.2011
SK08.06.2011
BG08.09.2011
GR09.09.2011
IS08.10.2011
PT10.10.2011
IE30.10.2011
LU30.10.2011
MC31.10.2011
Former [2013/25]AT08.06.2011
BE08.06.2011
CY08.06.2011
CZ08.06.2011
DK08.06.2011
EE08.06.2011
FI08.06.2011
LT08.06.2011
LV08.06.2011
MT08.06.2011
NL08.06.2011
PL08.06.2011
RO08.06.2011
SE08.06.2011
SI08.06.2011
SK08.06.2011
GR09.09.2011
IS08.10.2011
PT10.10.2011
IE30.10.2011
LU30.10.2011
MC31.10.2011
Former [2013/14]AT08.06.2011
BE08.06.2011
CY08.06.2011
CZ08.06.2011
DK08.06.2011
EE08.06.2011
FI08.06.2011
LT08.06.2011
LV08.06.2011
MT08.06.2011
NL08.06.2011
PL08.06.2011
RO08.06.2011
SE08.06.2011
SI08.06.2011
SK08.06.2011
GR09.09.2011
IS08.10.2011
PT10.10.2011
IE30.10.2011
MC31.10.2011
Former [2012/47]AT08.06.2011
BE08.06.2011
CY08.06.2011
CZ08.06.2011
DK08.06.2011
EE08.06.2011
FI08.06.2011
LT08.06.2011
LV08.06.2011
NL08.06.2011
PL08.06.2011
RO08.06.2011
SE08.06.2011
SI08.06.2011
SK08.06.2011
GR09.09.2011
IS08.10.2011
PT10.10.2011
IE30.10.2011
MC31.10.2011
Former [2012/31]AT08.06.2011
BE08.06.2011
CY08.06.2011
CZ08.06.2011
DK08.06.2011
EE08.06.2011
FI08.06.2011
LT08.06.2011
LV08.06.2011
NL08.06.2011
PL08.06.2011
RO08.06.2011
SE08.06.2011
SI08.06.2011
SK08.06.2011
GR09.09.2011
IS08.10.2011
PT10.10.2011
MC31.10.2011
Former [2012/25]AT08.06.2011
BE08.06.2011
CY08.06.2011
CZ08.06.2011
EE08.06.2011
FI08.06.2011
LT08.06.2011
LV08.06.2011
NL08.06.2011
PL08.06.2011
RO08.06.2011
SE08.06.2011
SI08.06.2011
SK08.06.2011
GR09.09.2011
IS08.10.2011
PT10.10.2011
MC31.10.2011
Former [2012/12]AT08.06.2011
BE08.06.2011
CY08.06.2011
CZ08.06.2011
EE08.06.2011
FI08.06.2011
LT08.06.2011
LV08.06.2011
NL08.06.2011
PL08.06.2011
RO08.06.2011
SE08.06.2011
SI08.06.2011
SK08.06.2011
GR09.09.2011
IS08.10.2011
PT10.10.2011
Former [2012/05]AT08.06.2011
BE08.06.2011
CY08.06.2011
FI08.06.2011
LT08.06.2011
LV08.06.2011
NL08.06.2011
SE08.06.2011
SI08.06.2011
GR09.09.2011
Former [2012/01]AT08.06.2011
CY08.06.2011
FI08.06.2011
LT08.06.2011
LV08.06.2011
NL08.06.2011
SE08.06.2011
SI08.06.2011
GR09.09.2011
Former [2011/52]AT08.06.2011
CY08.06.2011
FI08.06.2011
LT08.06.2011
LV08.06.2011
SE08.06.2011
SI08.06.2011
GR09.09.2011
Former [2011/50]CY08.06.2011
FI08.06.2011
LT08.06.2011
LV08.06.2011
SE08.06.2011
SI08.06.2011
GR09.09.2011
Former [2011/49]CY08.06.2011
FI08.06.2011
LT08.06.2011
SE08.06.2011
GR09.09.2011
Former [2011/48]LT08.06.2011
SE08.06.2011
Cited inInternational search[A]EP0947511  (HOFFMANN LA ROCHE [CH]) [A] 1,2 * tables 1,2 *;
 [A]  - HANS-DIETER ARNDT, DR., "Kleine Moleküle als Transkriptionsmodulatoren", ANGEWANDTE CHEMIE VOLUME 118, ISSUE 28 , PAGES 4664 - 4673, (20060703), XP002465843 [A] 1,2 * page 4668 - page 4669 *

DOI:   http://dx.doi.org/10.1002/ange.200600285
ExaminationWO2008141917
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.